Respiratorius AB
RESP | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0004550192 (+2 more)
- LEI:
- 5493001YRVZ5XYFEE615
- Country:
- Sweden
- Address:
- Scheeletorget 1, 223 81 Lund
- Website:
- https://www.respiratorius.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Respiratorius AB is a research-based pharmaceutical company focused on the development of innovative drug candidates. The company's primary focus is on oncology, specifically creating new treatments for aggressive forms of cancer such as diffuse large B-cell lymphoma (DLBCL). Its lead strategy involves developing a drug candidate intended as a pretreatment to enhance the efficacy of current standard therapies. Founded in 1999 as a spin-off from Lund University, Respiratorius leverages a team with extensive experience in clinical development, commercialization of research, and pharmaceutical business development. While historically involved in developing drugs for COPD and asthma, its current pipeline is centered on cancer.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Respiratorius AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Respiratorius AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Respiratorius AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-06 | Johan Drott | Other | Buy | 1,120 | N/A |
